Royalty Pharma plc (RPRX) Reports Q4 results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mail
Get Alerts RPRX Hot Sheet
Price: $56.21 -0.97%
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
PKE, BYRN, HELE, More
Financial Fact:
Total revenues and other income: 10K
Today's EPS Names:
PKE, BYRN, HELE, More
Join SI Premium – FREE
Royalty Pharma plc (NASDAQ: RPRX) reported Q4 Revenue for the quarter at $622 million versus the consensus estimate of $796.14 million.
For earnings history and earnings-related data on Royalty Pharma plc (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Humana soars, Alignment Healthcare sinks on Medicare rating changes
- Trinity Capital reports $880M in new commitments for Q3 2026
- Rochon family buys $26.8M in AIAI Holdings shares
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
